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QSAR-based molecular signatures 
of prenylated (iso)flavonoids 
underlying antimicrobial potency 
against and membrane-disruption 
in Gram positive and Gram negative 
bacteria
Carla Araya-Cloutier1, Jean-Paul Vincken1, Milou G. M. van de Schans1,2, Jos Hageman3,  
Gijs Schaftenaar4, Heidy M. W. den Besten5 & Harry Gruppen1
Prenylated flavonoids and isoflavonoids are phytochemicals with remarkable antibacterial activity. In 
this study, 30 prenylated (iso)flavonoids were tested against Listeria monocytogenes and Escherichia 
coli (the latter in combination with an efflux pump inhibitor). Minimum inhibitory concentrations of the 
most active compounds ranged between 6.3–15.0 µg/mL. Quantitative structure-activity relationships 
(QSAR) analysis was performed and linear regression models were proposed with R2 between 0.77–0.80, 
average R2m between 0.70–0.75, Q2LOO between 0.66–0.69, and relatively low amount of descriptors. 
Shape descriptors (related to flexibility and globularity), together with hydrophilic/hydrophobic volume 
and surface area descriptors, were identified as important molecular characteristics related to activity. A 
3D pharmacophore model explaining the effect of the prenyl position on the activity of compounds was 
developed for each bacterium. These models predicted active compounds with an accuracy of 71–88%. 
With regard to the mode of action, good antibacterial prenylated (iso)flavonoids with low relative 
hydrophobic surface area caused remarkable membrane permeabilization, whereas those with higher 
relative hydrophobic surface area did not. Based on the QSAR and membrane permeabilization studies, 
the mode of action of antibacterial prenylated (iso)flavonoids was putatively rationalized.
Interest in natural compounds for antimicrobial discovery has increased during the last decade due to the rise in 
highly resistant bacteria1. Natural products are a potentially rich source of compounds for antimicrobial discov-
ery and development, as they usually have a high degree of stereochemistry with an extensive variety of (ring) 
scaffolds and generally low toxicity2,3.
In the Fabaceae plant family, prenylated phenolic compounds have been identified as promising antimicro-
bials in extracts from elicited seedlings4,5. These phenolic compounds mainly belong to the flavonoid (2-phenyl 
benzopyrans), isoflavonoid (3-phenyl benzopyrans) and stilbenoid (1,2-diphenyl ethylene) classes. Besides the 
skeleton, they can differ in configuration and position of prenylation. Prenyl groups can be attached to a phe-
nolic compound as a chain (3,3-dimethylallyl substituent) or as a five- or six-membered ring after undergoing 
enzymatic cyclisation with an ortho-phenolic hydroxyl group6. Prenylation has been shown to increase the anti-
bacterial activity of phenolic compounds7, partly because hydrophobicity increases. Thereby, the partitioning to 
biological targets, such as membranes, increases8.
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Structure-antibacterial activity relationships (SAR) of prenylated (iso)flavonoids have been obtained by com-
paring the activity data and structures of a few analogues (usually ≤ 10 compounds)9,10. Studies have focused on 
describing the substituents and positions within a particular phenolic skeleton that provide high or low antibac-
terial activity11,12. The antibacterial activity of prenylated and non-prenylated (iso)flavonoids from licorice against 
methicillin-resistant Staphylococcus aureus (MRSA) and Gram negative bacteria has been studied13. None of the 
compounds were active against the Gram negative bacteria (minimum inhibitory concentration (MIC) >128 µg/
mL), but some were very active against MRSA, especially diprenylated (iso)flavonoids (MIC 8.0 µg/mL). It was 
also observed that the presence of a D-ring in a coumestan was detrimental for the activity, the effect of which was 
attributed to the rigidity of the skeleton. In contrast, a diprenylated 6a,11a-pterocarpene and a monoprenylated 
pterocarpan, both having rigid skeletons, were the most antibacterial compounds against MRSA (MIC 6.3 µg/
mL for both)14. In another study15, a diprenylated pterocarpan and diprenylated isoflavan were found to be very 
active (MIC 3.1–6.3 µg/mL) against vancomycin-resistant enterococci, whereas a diprenylated isoflavanone was 
not. Further studies showed that the position of the prenyl group(s) differently affected the antibacterial activity 
of different subclasses of (iso)flavonoids16,17. For flavanones, prenylation at C8 provided a higher antibacterial 
activity (i.e. MIC 12.5–25 µg/mL) than prenylation at C6 (MIC >100 µg/mL)18, whereas for isoflavones the oppo-
site result was found10. Regarding other substituents, the presence of hydroxyl groups appeared to be essential 
for antibacterial activity of prenylated (iso)flavonoids7. In contrast, the influence of methoxyl groups was more 
ambiguous, with reduced activity in some isoflavonoids14,19, and enhanced activity in others12,17,20.
Increase in hydrophobicity by the presence of prenyl groups has been the traditional explanation given for the 
increase in antibacterial activity observed upon prenylation of (iso)flavonioids8. However, not all prenylated (iso)
flavonoids have shown antibacterial activity18,21, highlighting the importance of other, yet to be defined, molecular 
characteristics for antibacterial activity. Furthermore, it has not been investigated in any large detail how differ-
ences in the overall molecular configuration relate to the mode of action. In this context, in silico approaches, like 
quantitative SAR (QSAR)22 and pharmacophore modelling23, can help to elucidate the physicochemical prop-
erties important for the antibacterial activity and mode of action. Despite numerous descriptive SAR studies 
of prenylated (iso)flavonoids, frequently with relatively few compounds, no QSAR analysis of prenylated (iso)
flavonoids as antibacterials has been performed so far.
In this study we report on the application of QSAR analysis to elucidate the main molecular characteristics of 
prenylated (iso)flavonoids as antibacterials. For this, we used the Gram positive Listeria monocytogenes and the 
Gram negative Escherichia coli as model organisms. We previously showed that intrinsic resistance in E. coli can 
be overcome by inhibiting the efflux pump systems5. Consequently, we here report the antibacterial activity of 
prenylated (iso)flavonoids against E. coli in combination with an efflux pump inhibitor. We tested 30 mono- and 
diprenylated (iso)flavonoids (Fig. 1), belonging to 6 different (iso)flavonoid subclasses, prenylated at different 
positions of the main skeleton and with chain, pyran or furan prenyl configurations. The majority of these mol-
ecules has never been tested before against L. monocytogenes, or against E. coli in the presence of an efflux pump 
Figure 1. Overview of the structures of the prenylated (iso)flavonoids, and subclass to which they belong, 
tested in this study.
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inhibitor. We determined the minimum inhibitory and bactericidal concentrations of all compounds, and ana-
lyzed the membrane permeabilization capacity of the antibacterial compounds.
The main goals of this study were (i) to develop a multiple linear regression model with high predictive capa-
bilities for the activity of other prenylated (iso)flavonoids by using a QSAR approach, and (ii) to understand 
the mode of action of prenylated (iso)flavonoids against Gram positive and Gram negative bacteria by linking 
the QSAR findings to the proposed mode of action of prenylated (iso)flavonoids, i.e. disruption of membrane 
integrity5,24–26.
Results
Table 1 shows the MICs and MBCs determined for each compound against each bacterium. Diprenylated glabrol 
(2) and 6,8-diprenylgenistein (16) were very good antibacterials against L. monocytogenes with both MIC and 
MBC values of 6.3 µg/mL. E.coli was not susceptible to any of the tested (iso)flavonoids up to 50 µg/mL. When the 
efflux pumps were inhibited by PAβN, E. coli became susceptible to a similar extent as L. monocytogenes (control 
samples with E. coli demonstrated no growth inhibition by PaβN alone, data not shown). In this way, monopre-
nylated glabridin and luteone showed very good antibacterial activity against E. coli with MICs of 10 µg/mL and 
MBCs of 15.0 µg/mL.
No. Name compound
L. monocytogenes E. coli + EPI
MIC MBC MIC MBC
Flavanone
1 6-Prenyl-naringenin >50 >50 25 25
2 Glabrol 6.3 6.3 >50 >50
Isoflavan
3 Glabridin 15 20 10 15
4 4′-O-methyl-glabridin 10 12.5 20 20
5 3′-OH-4′-O-methyl-glabridin 12.5 25 >50 >50
6 Hispaglabridin A 15 25 >50 >50
7 Hispaglabridin B 10 15 >50 >50
Isoflavene
8 Glabrene 35 50 50 50
Isoflavone
9 Licoisoflavone A 35 50 20 25
10 Isowighteone 20 20 25 25
11 Neobavaisoflavone 50 50 25 25
12 Luteone 20 50 10 15
13 Wighteone 10 15 15 15
14 2,3-Dehydrokievitone >50 >50 >50 >50
15 Lupiwighteone >50 >50 >50 >50
16 6,8-Diprenyl-genistein 6.3 6.3 >50 >50
17 Iso-osajin >50 >50 >50 >50
6a-OH-Pterocarpan
18 Glyceollidin II >50 >50 >50 >50
19 Glyceollin IV 50 >50 50 >50
20 Glyceollin I >50 >50 >50 >50
21 Glyceollin II >50 >50 >50 >50
22 Glyceollin III >50 >50 >50 >50
23 Glyceollin V >50 >50 >50 >50
24 Glyceofuran >50 >50 >50 >50
6a,11a-Pterocarpene
25 Dehydroglyceollidin II 12.5 15 50 >50
26 Dehydroglyceollin IV 25 35 >50 >50
27 Dehydroglyceollin I 20 20 >50 >50
28 Dehydroglyceollin II 20 25 >50 >50
29 Anhydrotuberosin >50 >50 n.t.c n.t.
30 Dehydroglyceollin III >50 >50 >50 >50
Table 1. Antibacterial activity of prenylated (iso)flavonoids. Minimum inhibitory concentration (MIC, µg/mL) and 
minimum bactericidal concentration (MBC, µg/mL) of prenylated (iso)flavonoids against L. monocytogenes EGD-e 
and against E. coli K12, the latter one in the presence of efflux pump inhibitor PaβN (48 µM). No antibacterial 
activity was observed against E. coli without the efflux pump inhibitor (MIC >50 µg/mL). n.t. Not tested.
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Effect of (iso)flavonoid subclass. In general, isoflavans and isoflavones were among the most active com-
pounds against both L. monocytogenes and E. coli (Table 1). Interestingly, most 6a-hydroxy-pterocarpans did 
not show antibacterial activity up to the highest concentration tested (MIC >50 µg/mL) against the two target 
bacteria, whereas 6a,11a-pterocarpenes were active against L. monocytogenes. Figure 2a illustrates the inhibition 
of growth of L. monocytogenes, when exposed to a chain prenylated 6a-hydroxy-pterocarpan (cPta, 18) and its 
equivalent chain prenylated 6a,11a-pterocarpene (cPte, 25) (the higher the TTD, the stronger the inhibition with 
a maximum of 24 h). As observed, the dehydration and formation of a double bond at position 6a in dehydro-
glyceollidin II (25) enhanced the antibacterial activity in comparison with glyceollidin II (18).
Effect of the configuration of prenyl group. Figure 2a also compares the inhibitory activity of three 
6a,11a-pterocarpenes sharing the same structure but different configuration of prenyl group. The chain preny-
lated 6a,11a-pterocarpene (cPte, 25) inhibited the growth of the bacteria at a minimum concentration of 12.5 µg/
mL (Fig. 2a). The pyran prenylated 6a,11a-pterocarpene (pPte, 28) was the next most active compound with a 
MIC of 20.0 µg/mL. Last, the furan prenylated 6a,11a-pterocarpene (fPte, 30) did not inhibit the growth at any 
concentration tested. Also, none of the furan prenylated compounds (22–24, 30) showed antibacterial activity 
against the target bacteria (Table 1).
Effect of the position of the prenyl group. Concerning the (iso)flavonoid skeletons, there are four main 
positions of C-prenylation: C6, C8, C3’ and C5’ (or the equivalents C2, C4, C8 and C10 in 6a-hydroxy-pterocarpans 
and 6a,11a-pterocarpenes). In order to compare different subclasses of (iso)flavonoids, the Greek numbering 
system of Simons et al6. was adopted, which is illustrated by the isoflavonoid skeleton in Fig. 2b. The position 
of the prenyl group clearly affected the antibacterial activity of these compounds. Lupiwighteone, chain pre-
nylated at the α position (α-cIso, 15), showed no inhibition towards L. monocytogenes, whereas β-prenylated 
Figure 2. Time to detection (TTD) of bacterial growth upon exposure to prenylated (iso)flavonoids. (a) TTD 
of L. monocytogenes growth in the presence of different prenylated 6a-hydroxy-pterocarpans (glyceollidin II, 18) 
and 6a,11a-pterocarpenes (dehydroglyceollidin II, 25; dehydroglyceollin II, 28; dehydroglyceollin III, 30). (b) 
TTD of L. monocytogenes growth in the presence of chain prenylated isoflavones (closed symbols): isowighteone 
(10), wighteone (13), lupiwighteone (15); and ring-closed prenylated pterocarpenes (open symbols): 
dehydroglyceollin I (27), dehydroglyceollin II (28), anhydrotuberosin (29). Prenyl positions are annotated 
based on the inset. (c) TTD of L. monocytogenes (solid line) and E. coli (with EPI, dashed line) growth in the 
presence of different prenylated isoflavans: glabridin (3), hispaglabridin A (6) and hispaglabridin B (7). Error 
bars represent the standard deviation of two biologically independent reproductions. TTD of control cells (i.e. 
cells not exposed to prenylated compounds) was 11.1 ± 2.9 h for L. monocytogenes and 6.9 ± 0.13 for E. coli.
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wighteone (β-cIso, 13) had high antibacterial activity, followed by δ-prenylated isowighteone (δ-cIso, 10). For 
6a,11a-pterocarpenes, activity was similar for α- and β-prenylated compounds, i.e. dehydroglyceollin I (α-rPte, 
27) and II (β-rPte, 28), whereas the δ-prenylated 6a,11a-pterocarpene, i.e. anhydrotuberosin (δ-rPte, 29), showed 
the lowest growth inhibition.
Effect of the number of prenyl groups. In Fig. 2c the growth inhibition of L. monocytogenes (solid line) 
and E. coli in the presence of the EPI (dashed line) by mono- and diprenylated isoflavans (Isa) is illustrated. Except 
for iso-osajin (17), diprenylated (iso)flavonoids were among the most active ones against the Gram positive bac-
terium (MIC ≤ 15 µg/mL). Diprenylated hispaglabridin A (c,pIsa, 6) and B (p,pIsa, 7) inhibited bacterial growth 
faster than monoprenylated glabridin (pIsa, 3). Opposite results were found for the Gram negative bacterium. 
Diprenylated (iso)flavonoids were not effective antibacterials against E.coli (Table 1), whereas monoprenylated 
compounds, including glabridin (3), were very active against this bacterium (MIC ≤ 15 µg/mL).
Effect of other substituents. The number of hydroxyl groups influenced the antibacterial activity of pre-
nylated isoflavones. The presence of 3 OH groups in the isoflavone skeleton as in isowighteone (10) was more 
effective against the Gram positive bacteria (MIC 20 µg/mL) than the presence of 4 OH groups as in licoisoflavone 
A (9, MIC 35 µg/mL) or than the presence of 2 OH groups as in neobavaisoflavone (11, MIC 50 µg/mL). For E. 
coli, the prenylated isoflavone with 4 OH groups (9, MIC 20 µg/mL) was slightly better antibacterial than preny-
lated isoflavones with 3 (10) or 2 OH groups (11, MIC 25 µg/mL). With regard to O-methylation, we found no 
clear effect on the antibacterial activity of prenylated (iso)flavonoids against L. monocytogenes. In the case of E. 
coli, O-methylation was detrimental for activity, as in dehydroglyceollidin II (25, MIC 50 µg/mL) in comparison 
with O-methylated dehydroglyceollin IV (26, MIC >50 µg/mL), or as in glabridin (3, MIC 15 µg/mL) in compar-
ison with 4’-O-methyl-glabridin (4, MIC 20 µg/mL).
QSAR analysis. QSAR of prenylated (iso)flavonoids was carried out to interpret the structural features 
responsible for their antibacterial activity against Gram positive L. monocytogenes and Gram negative E. coli 
(in combination with an efflux pump inhibitor). A genetic algorithm (GA) was used to explore which molecu-
lar descriptors were best able to predict the antibacterial activity using ordinary least square (OLS) regression. 
GA is an optimization technique that explores the descriptor space simultaneously by a population of candidate 
solutions (models), in which solutions compete and recombine27. Since the starting point of a GA run is always 
different, every GA run was repeated 5 times for a fixed subset of descriptors (varied from 3 to 8 descriptors). 
The best OLS models obtained per number of descriptor are summarized in Table 2 (criteria for selecting the 
best models are specified in Materials and Methods section). The descriptors used in the best GA-generated OLS 
models are specified in Table 3.
L. monocytogenes models. The top most frequently used descriptors (i.e. those with a frequency factor larger 
than 1 in Table 3) in the models of L.monocytogenes were related to the fraction of heavy atoms (rsynth, p-value 
0.008), molecular branching (KierA3, p-value 2 × 10−5), the relative hydrophilic surface (vsurf_CW6, p-value 
0.002), distribution of hydrophilic/hydrophobic regions (vsurf_A, p-value 0.003), and the location of hydrophobic 
interacting atoms or groups (vsurf_DD12, p-value 0.005).
Additionally, considering the sign (positive/negative) of the coefficient estimates of the descriptors in Table 3, 
the molecular properties that are important for antibacterial activity of prenylated (iso)flavonoids might be 
predicted. Specifically, shape related descriptors, i.e. molecular branching (KierA3, top descriptor), number of 
rotational bonds (b_rotN) and globularity (glob) were positively correlated with antibacterial activity, whereas 
density (dens), atom information content (a_ICM) and diameter (diameter) were negatively correlated with activ-
ity. This gave an indication that small flexible globular molecules were better for antibacterial activity against 
Bacteria k p-value R2 R2adj SE Q2LOO Q2LOO_adj VIFmax
L.monocytogenes
3 5.2e-06 0.6431 0.6020 0.2807 0.5537 0.5022 1.957
4 3.2e-05 0.6328 0.574 0.2904 0.6685 0.6155 4.844
5 4.6e-07 0.7735 0.7263 0.2328 0.6566 0.5850 1.592
6 4.9e-07 0.8007 0.7487 0.2230 0.6821 0.5991 3.413
7 3.8e-06 0.7886 0.7213 0.2349 0.7044 0.6103 4.732
8 1.5e-05 0.7866 0.7053 0.2415 0.6788 0.5564 4.567
E. coli
3 2.2e-05 0.6140 0.5677 0.2233 0.4955 0.4373 1.745
4 7.8e-06 0.6881 0.6361 0.2049 0.5736 0.5054 2.251
5 1.8e-07 0.8047 0.7623 0.1656 0.6921 0.6279 4.143
6 2.0e-06 0.7879 0.7301 0.1765 0.6620 0.5738 2.317
7 1.2e-07 0.8597 0.813 0.1469 0.7569 0.6795 4.358
8 7.0e-07 0.8564 0.7989 0.1523 0.7356 0.6349 3.999
Table 2. Statistical performance of the best OLS models obtained using GA-selection of variables for 
predicting antibacterial activity of prenylated (iso)flavonoids against L. monocytogenes and E. coli. k: number of 
descriptors; R2: coefficient of determination; R2adj: adjusted R2; SE: standard error of residuals; Q2LOO: leave-one-
out cross-validated coefficient of determination; Q2LOO_adj: adjusted Q2LOO; VIFmax: maximum variance inflation 
factor. The finally chosen OLS models are shown in bold.
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L. monocytogenes than large flat molecules. The hydrophilic surface (vsurf_CW6, top descriptor) and volume 
(vsurf_W) were positively correlated with activity, but having separate hydrophilic and hydrophobic regions 
within the molecule seems to be detrimental for activity, as the amphiphilic moment (vsurf_A, top descriptor) 
was negatively correlated with activity. The (positive/negative) contribution of other (top) descriptors (e.g. rsynth, 
vsurf_DD, vsurf_IW) in relation to antibacterial activity remains difficult to interpret and needs further study.
E. coli models. The top most frequently used descriptors (i.e. those with a frequency factor larger than 1 in 
Table 3) in the models of E. coli were related to molecular shape (std_dim3, p-value 0.0002; npr1, p-value 0.002), 
the distribution of hydrophilic regions (vsurf_IW2, p-value 7 × 10−5), the number of hydrogen bond acceptors 
(a_acc, p-value 0.01), the number of hydrophobic atoms (a_hyd, p-value 8 × 10−5), and molecular flexibility (rgyr, 
p-value 0.0001). Specifically, globularity, illustrated by the descriptor std_dim3 (top descriptor), was positively 
correlated with antibacterial activity against E. coli. Together with the negative correlation with activity of the nor-
malized principal moment of inertia 1 (npr1, top descriptor), this indicated overall that a globular shape, rather 
than a flat shape, is better for activity. Flexibility was positively correlated with antibacterial activity, illustrated by 
the positive correlation of the radius of gyration (rgyr, top descriptor). Hydrophobicity, illustrated by the number 
of hydrophobic atoms (a_hyd, top descriptor) and the octanol water partition coefficient (logPo/w), was negatively 
correlated with activity against E. coli. Other (top) descriptors showed positive and negative coefficient estimates 
in the different models, making interpretation of their contribution to antibacterial activity difficult.
Based on the statistical performance of the GA-generated OLS models (Table 2) and the number of descriptors 
(ratio between number of compounds and number of descriptors ≥ 5 for a good model)28, the models for best 
predicting the antibacterial activity of prenylated (iso)flavonoids are highlighted in bold in Table 2 and detailed in 
Table 4. As observed, selected OLS models showed R2 between 0.77–0.80, average R2m between 0.70–0.75, good 
predictive power (Q2 >0.65), and no outliers.
Pharmacophore elucidation with antibacterial prenylated (iso)flavonoids. Some prenylated com-
pounds showed different antibacterial activity, but had almost the same structure and chemical properties, except 
for the position of the prenyl group. To extend the understanding of the effect of the position of prenylation on 
antibacterial activity we employed ligand-based pharmacophore elucidation to model the structural requirements 
of prenylated (iso)flavonoids for antibacterial activity against L. monocytogenes (Fig. 3a) and E. coli (Fig. 3b). 
The 3D pharmacophore models were similar for both bacteria, consisting of one hydrophobic feature (green, 
at the location of the prenyl group), two aromatic ring features (orange corresponding to the A- and B-ring of 
(iso)flavonoids), and one (for L. monocytogenes) or two (for E. coli) hydrogen bond acceptor projection features 
L. monocytogenes E. coli
Descriptor F p-value Sign Descriptor F p-value Sign
a_ICM 1 1.8E−06 − a_acc 2 4.8E−06–0.0149 −
ast_violation 1 0.0019 + a_hyd 2 8.0E−06–8.5E−05 −
b_rotN 1 0.0185 + b_count 1 8.4E−07 −
dens 1 0.0326 − b_single 1 0.0006 −
diameter 1 0.0088 − logPo/w 1 0.0055 −
glob 1 0.1308 + npr1 2 0.0003–0.0018 −
h_ema 1 8.1E−05 − PEOE_VSA+0 1 0.0139 −
KierA3 2 1.2–2.2E−05 + petitjeanSC 1 0.0028 −
rsynth 5 2.1E−05–0.0085 + rgyr 2 1.1E−05–0.0001 +
vdw_area 1 0.0019 + RPC+ 1 0.0012 +
vsurf_A 2 0.0015–0.0027 − SlogP_VSA0 1 0.2686 −
vsurf_CP 1 0.1804 + std_dim3 6 8.6E−08–0.0002 +
vsurf_CW2 1 0.6293 − vsurf_A 1 0.0011 −
vsurf_CW6 3 0.0045–0.0191 + vsurf_CW1 1 0.0808 +
vsurf_DD12 3 0.0001–0.0049 − vsurf_EDmin1 1 0.0076 +
vsurf_DW12 1 0.1013 − vsurf_IW1 1 0.0002 +
vsurf_ID8 1 0.0111 + vsurf_IW2 3 5.1E−06–7.3E−05 +
vsurf_IW4 1 0.0078 − vsurf_IW4 1 0.0004 −
vsurf_IW5 1 0.0484 + vsurf_IW5 1 0.0023 −
vsurf_IW6 1 0.1961 + vsurf_IW6 1 0.0005 −
vsurf_IW7 1 0.1350 − vsurf_W7 1 0.0190 −
vsurf_W4 1 0.0114 + zagreb 1 0.0002 −
vsurf_W6 1 0.0004 +
Table 3. Descriptors present in the best OLS regression models obtained for predicting the antibacterial activity 
against L. monocytogenes and E. coli. F: selection frequency in best GA-generated models; p-value: significance 
of descriptor coefficient in the models; Sign: sign of descriptor coefficient. Descriptor meaning can be found in 
Supplementary Table S3.
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(blue). A projection feature defines the position of a potential hydrogen bond partner. Using an activity threshold 
of a MIC value of 25 µg/mL, these two pharmacophore models were able to predict which compounds and, thus 
prenylation positions, were good for antibacterial activity. These models showed a 76–83% overall accuracy, i.e. 
proportion of true positives and negatives results (Supplementary Tables S1 and S2). Figure 3c shows examples 
of good antibacterial compounds (glabridin (3), luteone (12) and licoisoflavone A (9)) prenylated at different 
positions in relation to their mapping of the E. coli pharmacophore model. The aromatic (orange) and hydrogen 
Microorganism N R2 R2adj R2m_av Q2LOO Q2LOO_adj Outliers Descriptor Coefficient
Standard 
error p-value VIF
L. monocytogenes 30 0.77 0.73 0.70 0.66 0.59 no
KierA3 0.40 0.07 1.2 × 10−5 1.26
rsynth 1.13 0.21 2.1 × 10−5 1.32
vsurf_DD12 −0.07 0.02 0.0001 1.14
vsurf_IW4 −0.16 0.05 0.008 1.24
vsurf_ID8 0.29 0.11 0.01 1.59
Intercept 2.71 0.36 8.6 × 10−8 —
E. coli 29 0.80 0.76 0.75 0.69 0.62 no
b_count −0.06 0.01 8.4 × 10−7 2.39
std_dim3 1.54 0.23 1.3 × 10−6 1.76
vsurf_IW2 0.74 0.14 3.1 × 10−5 4.14
rgyr 0.80 0.17 0.0001 2.19
vsurf_IW4 −0.28 0.07 0.0004 3.72
Intercept 1.60 0.63 0.02 —
Table 4. Selected GA-MLR models developed for predicting the antibacterial activity of prenylated (iso)
flavonoids. N: number of compounds used for building the model; R2: Correlation coefficient; R2adj: adjusted 
R2; R2m_av: average modified R2 (based on scaled activity values)a; Q2LOO: leave-one-out cross-validated 
correlation coefficient; Q2LOO_adj: adjusted Q2; Outliers: presence of outliersb; VIF: variance inflation factor. 
Descriptor meaning can be found in Supplementary Table S3. aRegression plots for calculating the R2m_av are 
in Supplementary Figure S1. b The presence of outliers was evaluated with the standardization approach59 
(Supplementary Figure S2).
Figure 3. Ligand-based pharmacophore model for antibacterial (MIC ≤ 25 µg/mL) prenylated (iso)flavonoids 
against L. monocytogenes (a) and E. coli (b). The color of the spheres represents the following features: blue 
spheres are hydrogen bond acceptor projection features (i.e. feature that annotates the location of a possible 
hydrogen bond partner), whereas green and orange spheres represent hydrophobic areas or aromatic rings, 
respectively, in the ligand. Distance between the features are in Ångström. Overall accuracy, i.e. proportion 
of correctly predicted compounds (positives and negatives); positive accuracy, i.e. proportion of correctly 
predicted positive compounds (those with good antibacterial activity); negative accuracy, i.e. proportion 
of correctly predicted negative compounds (those with moderate to low antibacterial activity). (c) Good 
antibacterial (iso)flavonoids, prenylated at different positions and with different configurations, fitting E. coli’s 
pharmacophore model.
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bond acceptor (blue) features can be mapped by most prenylated (iso)flavonoids. However, inactive compounds 
are unable to map the hydrophobic feature (green) with their prenyl groups.
Some compounds were falsely predicted as positive during the pharmacophore search (Supplementary 
Table S2). Diprenylated compounds were able to map E. coli’s pharmacophore features and consequently predicted 
as active, although no MIC value was found against E. coli. The same result was observed for the α-prenylated 
6a-hydroxy-pterocarpan (incorrectly predicted as active). To reach (i.e. permeate) the inner membrane, hydro-
phobicity is known to be determinant. These false positive results might be explained by an inappropriate hydro-
phobicity of these molecules: hydrophobicity might be too high for the diprenylated molecules to cross the OM 
of E. coli, or too low to permeate to the inner membrane for the 6a-OH-pterocarpan.
Membrane permeabilization by antibacterial prenylated (iso)flavonoids. Permeabilization of the 
cytoplasmic membrane of L. monocytogenes and E. coli, the latter in the presence and absence of EPI, was assayed 
by measuring the uptake of the fluorescent probe propidium iodine (PI). Figure 4a,c show the net PI uptake by L. 
monocytogenes and E. coli upon exposure to different antibacterial prenylated (iso)flavonoids (i.e. MIC <25 µg/
mL) and traditional antimicrobials. As observed, membrane permeabilization was immediate when treating the 
cells with some antibacterial prenylated compounds (e.g. luteone and licoisoflavones A). Figure 4b,d show the 
net PI uptake by L. monocytogenes and E. coli after 2 h of exposure to different prenylated (iso)flavonoids. The 
monoprenylated isoflavones isowighteone (10), luteone (12) and wighteone (13) were good membrane permea-
bilizers (i.e. PI uptake >500 RFU) of L. monocytogenes. Unexpectedly, other active compounds, including some 
diprenylated compounds, showed little change in fluorescence (PI uptake <100 RFU). In the case of E. coli, gla-
bridin (3), licoisoflavone A (9), luteone (12) and wighteone (13) were good membrane permeabilizers of E. coli 
in the presence of the EPI (i.e. PI uptake >500 RFU). Interestingly, these compounds were able to permeabilize 
without the EPI, although to a lesser extent than when EPI was present (i.e. PI uptake <500 RFU). This indicated 
that monoprenylated isoflavones were able to permeabilize E. coli cells (as some PI uptake occurred), but no lethal 
permeabilization took place as no MIC or MBC were found under those conditions. It cannot be excluded that 
recovery of PI permeable cells has occurred, as this has been observed previously for other microorganisms29.
Because hydrophobicity and shape were important molecular characteristics correlated with antibacterial 
activity according to the QSAR analysis, these properties were also expected to affect the membrane permeabi-
lization properties of antibacterial prenylated (iso)flavonoids. Interestingly, we found a significant (p 1.6 × 10–7) 
negative correlation (Fig. 5a) between permeabilization and relative hydrophobic surface area of the compounds. 
The good antibacterials that showed poor or no membrane permeabilization had a relatively larger hydrophobic 
surface area (>85%) than the good antibacterials that showed good membrane permeabilization. Figure 5b shows 
examples of good antibacterial compounds against L. monocytogenes with different permeabilization capacity, 
colored according to hydrophobicity and polarity.
Figure 4. Membrane permeabilization by antibacterial prenylated (iso)flavonoids. PI net uptake by L. 
monocytogenes (a) and E. coli (c) upon exposure to antibacterial prenylated (iso)flavonoids. Signal from the 
control cells (untreated, with and without EPI has been subtracted). Overall net PI uptake by L. monocytogenes 
(b) and E. coli (d) after 2 h of exposure to antibacterial prenylated (iso)flavonoids and antibiotics (at 20 µg/mL). 
Dashed lines represent the ranges used to defined non-permeabilizers (PI uptake <100 RFU), poor (PI uptake 
100–500 RFU) and good permeabilizers (PI uptake >500 RFU). Data are means of two independent biological 
reproductions, with standard deviations as error bars. Number of compound refers to those in Table 1. 
Ampicillin (Amp), ciprofloxacin (Cip), heat-treated cells (Heat).
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Discussion
Not all prenylated (iso)flavonoids tested in this study showed potent antibacterial activity, suggesting that increase 
of hydrophobicity by prenylation alone does not warrant antibacterial activity and that structural details might 
have a profound effect on antibacterial potency. From the QSAR analysis, shape (flexibility and globularity) and 
hydrophilicity/hydrophobicity related descriptors were found to be important for the antibacterial activity of 
prenylated (iso)flavonoids against both L. monocytogenes and E. coli (in the presence of an EPI). Additionally, a 
specific distribution of functional groups was illustrated by a 3D pharmacophore model, which can be used for 
predicting the position of prenylation required for antibacterial activity.
Importance of hydrophobicity on antibacterial activity of prenylated (iso)flavonoids. The effect 
of hydrophobicity of compounds on antibacterial activity was bacterium-dependent. Diprenylated (iso)flavo-
noids were effective against Gram positive L. monocytogenes but not against E. coli. Analyzing the logD of the 
effective compounds against these bacteria (Figure S3), the minimum hydrophobicity for prenylated (iso)flavo-
noids to be active against L. monocytogenes and E. coli corresponded to a logD of 3.6, whereas for E. coli there was 
also a maximum corresponding to a logD of 4.5. These differences in hydrophobicity requirements between L. 
monocytogenes and E. coli might be explained by their different influx pathways. In E. coli the entrance to the peri-
plasmic space of small (MW <600–700) and hydrophilic antimicrobials is usually through the nonspecific porins. 
These are narrow (6–15 Å diameter) hydrophilic channels with exposed negatively charged residues30–32. Because 
of the porin’s charged lining, hydrophobicity of antimicrobials has been shown to strongly reduce their influx 
rates through porins33. Alternatively, diffusion across the lipid bilayer of the outer membrane (OM), composed of 
lipopolysaccharides packed in a highly ordered fashion, is known to be very slow for hydrophobic compounds34. 
There are other substrate-specific (active) transporters in the OM, however, they require substrate recognition32,35. 
Flexibility and “3-dimensionality” (including globularity) were also important characteristics in a previous study 
affecting the accumulation of small traditional antimicrobials inside E. coli36. Having a low number of rotatable 
bonds (<6) and a globularity lower than 0.29 (where 0 represents a plane and 1 a sphere) improved the accumula-
tion inside Gram negative bacteria. All prenylated (iso)flavonoids tested in the present study complied with those 
requirements (active prenylated compounds against E. coli had ≤ 3 rotatable bonds and a globularity of ≤ 0.1). 
Therefore, shape does not seem to be the limiting factor for entrance of prenylated compounds into E. coli cell 
envelope.
There are no studies regarding the pathway of influx of prenylated (iso)flavonoids into Gram negative bac-
terial cells. Nevertheless, based on (i) the high substrate specificity of the specialized OM transporters35,37, (ii) 
the known porin-mediated entrance of antimicrobials of similar size, shape (flexibility and globularity) and 
hydrophobicity as our (active) prenylated (iso)flavonoids34,36,38, (iii) the observed detrimental effects of hydro-
phobicity, and (iv) the beneficial effects of extra polar groups in prenylated (iso)flavonoids regarding E. coli anti-
bacterial activity (Table 1), we postulate that prenylated (iso)flavonoids mainly enter via the unspecific porins. 
Consequently, the rate of influx through porins and thus the efficiency in inhibiting E. coli decreases as the hydro-
phobicity of the prenylated compound increases (e.g. as in diprenylated compounds). In contrast, because of the 
absence of the OM in Gram positives, (di)prenylated (iso)flavonoids have no hydrophobicity restrictions to enter 
the cell envelope39.
Importance of molecular shape on antibacterial activity of prenylated (iso)flavonoids. Besides 
antibacterial uptake and accumulation, effective interactions with the target site are essential for antibacte-
rial action. Because of the relatively high hydrophobicity of prenylated (iso)flavonoids (usually logD >3), it is 
expected that these compounds have high affinity towards the cytoplasmic membrane. Flexibility has been shown 
to be a mechanical determinant for membrane-interacting antimicrobial peptides. Peptides require some degree 
Figure 5. Correlation between the membrane permeabilization capacity (indicated by the PI uptake) of 
antibacterial prenylated (iso)flavonoids (i.e. MIC <25 µg/mL) and the relative hydrophobic surface area of the 
molecules (a). Molecular surface of active prenylated (iso)flavonoids with different membrane permeabilization 
properties (b). Surface color is yellow for hydrophobic areas and light blue for polar areas. Number below each 
molecule refers to the relative hydrophobic surface area, as calculated by MOE (PEOE_VSA_FHYD).
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of conformational freedom to partition into membranes as well as to arrange effective intermolecular interactions 
by rearranging their flexible side chains40–42. In line with this, we propose that chain prenylated (iso)flavonoids are 
able to rearrange more effectively than ring-closed prenyl groups, as prenyl chains are more flexible than prenyl 
rings. These rearrangements will improve their intermolecular interactions with a potential target. The positive 
correlation of globularity with antibacterial activity of prenylated (iso)flavonoids is in accordance with our previ-
ous results5, where flatness of prenylated stilbenoids was associated with their relatively low antibacterial activity 
as opposed to the relatively good antibacterial activity of elbow-shaped prenylated (iso)flavonoids.
Membrane permeabilization by prenylated (iso)flavonoids. We measured the level of membrane 
permeabilization by antibacterial prenylated (iso)flavonoids as an indicator of membrane integrity. Interestingly, 
we observed a significant (p < 0.01) negative correlation between membrane permeabilization and the relative 
hydrophobic surface area of antibacterial prenylated compounds. Hydrophobicity has been proposed to affect the 
localization of (prenylated) flavonoids within model membranes (liposomes)26,43. The difference in distribution 
along the phospholipids, and consequently, along the membrane might be responsible for the effectiveness in 
permeabilization observed in this study. Compounds interacting closer to the surface of the membrane, near the 
polar head groups (i.e. those with relatively lower hydrophobic surface area), might permeabilize the membrane 
more efficiently than compounds interacting deeper in the membrane (those with relatively higher hydrophobic 
surface area).
In general, these findings indicate that permeabilization is not the sole mechanism of action of these antibacte-
rial compounds. Because of their high hydrophobicity, it is still expected that these compounds have high affinity 
towards the cytoplasmic membrane. Membrane integrity might also be disrupted by other mechanisms, such as 
alteration of membrane fluidity or elasticity, alteration of hydration of membrane surface, alteration of membrane 
conductivity, or induction of lipid peroxidation43,44.
Mode of action of prenylated (iso)flavonoids revisited. The proposed effects of hydrophobicity and 
shape of (iso)flavonoids on their partitioning, accumulation in the bacterial inner membrane, and disruption of 
membrane integrity (which includes permeabilization but also other undefined mechanisms), are summarized 
in Fig. 6. In the Gram positive bacterium, prenylated compounds are not expected to encounter considerable 
barrier effects by the peptidoglycan layer to reach the cytoplasmic membrane where they can integrate, provided 
that the minimum hydrophobicity is met (as is the case for all compounds shown in Fig. 6). In the Gram negative 
bacterium, highly hydrophobic compounds (e.g. 6,8-diprenyl-genistein, dark green compound) encounter influx 
restrictions due to porins, but compounds meeting the hydrophobicity restrictions of porins can cross the outer 
membrane of Gram negatives. In the presence of a broad efflux pump inhibitor, such as PaβN, these prenylated 
(iso)flavonoids can pass the outer membrane and remain inside the periplasm. Flexible globular compounds 
(e.g. chain prenylated isoflavones, such as wighteone or 6,8-diprenyl-genistein, represented in Fig. 6 by deformed 
circles inside the membrane) are able to adapt their conformation to make effective intermolecular interactions 
with their target (proposed here to be in the cytoplasmic membrane). Less flexible and flat compounds (e.g. pyran 
prenylated pterocarpenes, such as dehydroglyceollin III) will have more limitations to interact effectively with the 
target site (as for the red compound). Consequently, they show less antibacterial activity, despite their hydropho-
bicity. Fast permeabilization by prenylated compounds might occur when they interact closer to the polar head 
groups of the phospholipids (indicated by orange shadow in the head groups). When the compound permeates 
deeper into the membrane due to their higher relative hydrophobic surface area, other disruption effects (e.g. 
alteration of membrane fluidity) might occur.
This is the first report on the QSAR of prenylated (iso)flavonoids as antibacterials against Gram positive and 
Gram negative bacteria. Important molecular characteristics identified in this study can be used for the design 
and development of novel antibacterials from these natural compounds.
Materials and Methods
Materials. Prenylated isoflavonoids (glabrene, 3′-hydroxy-4′-O-methyl-glabridin, 4′-O-methyl-glabridin, 
hispaglabridin A, hispaglabridin B, glyceofuran, glyceollidin II, glyceollin I, glyceollin II, glyceollin III, glyceollin 
IV, glyceollin V, dehydroglyceollidin II, dehydroglyceollin I, dehydroglyceollin II, dehydroglyceollin, III, dehy-
droglyceollin IV) and one prenylated flavone (glabrol) were previously purified and chemically characterized45,46. 
6-Prenylnaringenin, propidium iodine (PI), Phe-Arg β-naphthylamide dihydrochloride (PaβN), ampicillin and 
ciprofloxacin were purchased from Sigma Aldrich (St. Louis, MO, USA). Isowighteone and anhydrotuberosin 
were purchased from ChemFaces (Wuhan, Hubei, China). Wighteone, lupiwighteone, isowighteone, luteone, 
2,3-dehydrokievitone, licoisoflavone A, neobavaisoflavone, iso-osajin and 6,8-diprenygenistein were purchased 
from Plantech UK (Reading, UK). Bacto brain heart infusion (BHI) broth was purchased from BD (Franklin 
Lakes, NJ, USA), tryptone soya broth (TSB) and bacteriological agar from Oxoid Ltd (Basingstoke, UK), and 
peptone physiological salt solution (PPS) from Tritium Microbiologie (Eindhoven, The Netherlands). Ethanol 
absolute (EtOH) was purchased from Biosolve (Valkenswaard, The Netherlands).
Antibacterial activity. Compounds were tested for their antimicrobial activity against Gram positive 
Listeria monocytogenes EGD-e and Gram negative Escherichia coli K12. For the latter, the experiments were con-
ducted in the presence and absence of the efflux pump inhibitor PaβN.
Bacteria were streaked from a −80 °C glycerol stock onto a BHI agar plate and incubated 24 h at 37 °C. Next, 
one colony was transferred to BHI broth (10 mL) and further incubated for 18 h at 37 °C. These overnight cultures 
were diluted with TSB (final inoculum concentration 3.4 ± 0.4 log10 CFU/mL for L. monocytogenes and 4.2 ± 0.1 
log10 CFU/mL for E. coli). Stock solutions of the different prenylated compounds were prepared in EtOH (96% 
v/v) and subsequently diluted with TSB. Equal volumes (100 µL) of bacteria and prenylated compound solutions 
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(final concentrations tested of prenylated (iso)flavonoids 5–50 µg/mL, 2.5% v/v EtOH max.) in TSB were mixed 
into a 96-well plate. For E. coli, the efflux pump inhibitor (EPI) PAβN was added in the medium to a concentra-
tion of 25 µg/mL (48 µM)47. The 96-well plate was incubated in a SpectraMax M2e (Molecular Devices, Sunnyvale, 
CA, USA), at 37 °C with constant linear shaking. The optical density (OD) at 600 nm was measured every 5 min 
for 24 h.
Positive controls (ampicillin at 10 µg/mL), negative controls (TSB suspension of bacteria with 2.5% (v/v) 
EtOH) and blanks (extracts and TSB medium with no bacteria) were considered for optical comparison and ste-
rility control. Inhibition of growth was assessed by measuring the time to detection (TTD), i.e. the time to reach 
a change in OD of 0.05 units48. When no change in OD (i.e. ΔOD <0.05) was observed after the 24 h of incuba-
tion, cell viability was verified by plate counting. Briefly, 100 µL of the well with no change in OD was decimally 
diluted in PPS solution and 100 µL of each dilution was spread onto BHI agar plates. Plates were incubated for 
24 h at 37 °C and colonies were counted. The minimum inhibitory concentration (MIC) was defined as the lowest 
concentration of compound that resulted in a bacterial count equal or lower than that of the initial inoculum. The 
minimum bactericidal concentration (MBC) was defined as the lowest concentration of compound that resulted 
in >99% bacterial inactivation from the initial bacterial inoculum. Prenylated compounds were tested in two 
independent biological reproductions, each performed in duplicate.
Cell membrane permeability. To investigate the effects on the cytoplasmic membrane permeability, the 
fluorescent probe propidium iodine (PI) was used. Bacteria (−80 °C glycerol stock) were streaked onto a BHI 
agar plate and incubated overnight at 37 °C. Subsequently, one colony was transfer to 50 mL of BHI broth and 
incubated at 25 °C for 13 h. Cells were harvested by centrifugation (4696 g, 4 °C, 20 min) and washed twice with 
PPS (pH 7.2). The final cell pellet was suspended in 5 mL PPS to obtain an inoculum of 9.9 ± 0.3 log10 CFU/mL. 
Stock solutions of PI and prenylated compounds were diluted in PPS to concentrations of 60 µM and 40–80 µg/
mL, respectively. A volume of 50 μL of each solution (final concentration in test of PI 15 µM and of compounds 
Figure 6. Schematic overview of the main molecular characteristics found in this study to influence 
the antibacterial action of prenylated (iso)flavonoids against Gram positive and Gram negative bacteria. 
Compounds with green outline are good antibacterials (i.e. MIC <25 µg/mL). The intensity of the green shading 
in the compounds indicates the extent of hydrophobicity (with a minimum hydrophobicity of logD 3.6). 
Compound with red outline and red shading indicates a hydrophobic molecule (logD ≥ 3.6) with moderate or 
low antibacterial activity. Globular and flexible compounds were good antibacterials (indicated by the deformed 
shape). The compound with moderate/low antibacterial activity is a non-flexible planar molecule. Green 
shading around the phospholipids represents permeabilization.
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10–20 µg/mL, 2% (v/v) EtOH max.) and 100 µL of inoculum were added to a black with clear bottom 96-well plate 
(Greiner Bio One, Kremsmünster, Austria). Emission of fluorescence was measured every 30 s at 620 nm (bottom 
read mode), while exciting the sample at 520 nm, using a Spectramax M2e. For the positive control, cells were 
treated for 10 min at 95 °C in a Thermomixer (Eppendorf, Hamburg, Germany) and added as inoculum, whereas 
blank control contained 100 μL of PPS instead of inoculum. Tests with the antimicrobials ciprofloxacin and ampi-
cillin (10–20 µg/mL) were included for comparison. Intrinsic fluorescence or quenching effects of the compounds 
and of PI were considered by the use of blanks (compounds with PI, without cells; PI without cells). Compounds 
were tested in two independent biological reproductions, each performed in duplicate.
QSAR modeling. Molecular Operating Environment (MOE, version 2016.0802, Chemical Computing 
Group, Montreal, QC, Canada) was used to calculate 2D and internal 3D (i3D) molecular descriptors of preny-
lated (iso)flavonoids (full list of descriptors is in Supplementary Table S3), after structure preparation (MOPAC 
PM3 energy minimization, gradient 0.01 kcal/Å). Highly correlated (|R| ≥ 0.99) and constant descriptors were 
eliminated from the list. Antibacterial activity, expressed as pMIC (i.e. –logMIC, in molar)49,50, was used as the 
dependent variable. To take into account the complete structural diversity of the tested molecules, inactive mol-
ecules with a MIC >50 µg/mL were included by imputing a MIC 100 µg/mL (i.e. the next 2-fold higher concen-
tration to be tested) during the ordinary least squares (OLS) regression analysis. As the amount of compounds 
was relatively low (30 compounds), separation of the dataset into training and test sets is not recommended due 
to higher risks of chance correlation and overfitting51,52. Based on Tropsha (2010), the minimum number of com-
pounds should be no less than 40 for splitting the dataset53; therefore all compounds tested in our study were used 
for building the QSAR models.
A genetic algorithm (GA)54 was used to select a fixed subset of predictors best able to predict the antibacte-
rial activities using OLS. The GA parameters were optimized using a full factorial experiment design and were 
determined to be: population size = 100, cross-over rate = 0.6, mutation rate = 0.5. The maximum number of 
iterations was set to 200 and elitism set to 10. The number of predictors to be selected during a GA run was varied 
between 3 and 8. To exclude lucky or unlucky GA runs, every run was repeated 5 times with different starting 
seeds (Supplementary Figure S4). Models were assessed based the following statistical parameters: (i) significance 
(p-value); (ii) coefficient of determination (R2); (iii) adjusted coefficient of determination (R2adj); (iv) residual 
standard error (SE); (v) leave-one-out cross-validation (LOOCV) coefficient of determination (Q2LOO), to assess 
the model’s internal predictivity; (vi) the difference between R2 and Q2 <0.30, to avoid overfitting;55 (vii) adjusted 
LOOCV coefficient of determination (Q2LOO_adj), to allow comparison between models with different number 
of variables;56,57 (viii) variance inflation factor (VIF), to assess descriptor inter-correlation or multicollinearity. 
When VIF values were >5 the combination of predictors was penalized during the GA, effectively removing the 
solution from the population. Last, the finally selected models per bacterium were further internally validated 
by calculating: (i) the average modified coefficient of determination (R2m_av), based on the scaled values of the 
observed and predicted response data58; (ii) the applicability domain to identify outliers in the dataset, based on 
the standardization approach59.
Ligand-based pharmacophore elucidation. The pharmacophore elucidation query module of MOE was 
used to build a pharmacophore model. This is done by aligning the multiple ligands in the training set (i.e. energy 
minimized 3D structures) and determining the essential common chemical features to construct the model23. All 
compounds (i.e. 30 compounds tested for L. monocytogenes and 29 tested compounds for E. coli) were part of the 
training set and an activity of MIC 25 µg/mL was set to discriminate good antibacterial activity and moderate/low 
activity. As the exact interactions and target site of these compounds are unknown, the relevance of each feature 
(i.e. hydrogen bond acceptor, hydrogen bond donor, hydrophobic atoms and aromatic rings) was considered 
equal.
Models obtained were ranked and selected based on the accuracy of the pharmacophore in discriminating 
positive (i.e. good antibacterial activity) and negative (moderate/low activity) compounds. Accuracies of the 




Overall accuracy proportion of total correct predictions (true positives and true negatives);
Positive accuracy (sensitivity) proportion of correctly predicted positive results;
Negative accuracy (specificity) proportion of correctly predicted negative results
Data availability. The descriptor dataset generated for tested prenylated (iso)flavonoids is available on 
request.
References
 1. World Health Organization. (2014). Antimicrobial resistance: global report on surveillance 2014. Geneva, Switzerland.
 2. Harvey, A. L., Edrada-Ebel, R. & Quinn, R. J. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. 
Drug Discov. 14, 111–129 (2015).
 3. Upadhyay, A., Upadhyaya, I., Kollanoor-Johny, A. & Venkitanarayanan, K. Combating pathogenic microorganisms using plant-
derived antimicrobials: A minireview of the mechanistic basis. BioMed Res. Int. 2014, 1–18 (2014).
 4. Araya-Cloutier, C., den Besten, H. M. W., Aisyah, S., Gruppen, H. & Vincken, J.-P. The position of prenylation of isoflavonoids and 
stilbenoids from legumes (Fabaceae) modulates the antimicrobial activity against Gram positive pathogens. Food Chem. 226, 
193–201 (2017).
 5. Araya-Cloutier, C., Vincken, J.-P., van Ederen, R., den Besten, H. M. W. & Gruppen, H. Rapid membrane permeabilization of 
Listeria monocytogenes and Escherichia coli induced by antibacterial prenylated phenolic compounds from legumes. Food Chem. 
240, 147–155 (2018).
www.nature.com/scientificreports/
13SCIeNTIFIC REPORtS |  (2018) 8:9267  | DOI:10.1038/s41598-018-27545-4
 6. Simons, R., Gruppen, H., Bovee, T. F. H., Verbruggen, M. A. & Vincken, J.-P. Prenylated isoflavonoids from plants as selective 
estrogen receptor modulators (phytoSERMs). Food Funct. 3, 810–827 (2012).
 7. Tsuchiya, H. et al. Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant 
Staphylococcus aureus. J. Ethnopharmacol. 50, 27–34 (1996).
 8. Botta, B. et al. Prenylated isoflavonoids: Botanical distribution, structures, biological activities and biotechnological studies. An 
update (1995-2006). Curr. Med. Chem. 16, 3414–3468 (2009).
 9. Mbaveng, A. T. et al. Antimicrobial activities of the methanol extract and compounds from the twigs of Dorstenia mannii 
(Moraceae). BMC Complement. Altern. Med. 12, 1–6 (2012).
 10. Sato, M., Tanaka, H., Tani, N., Nagayama, M. & Yamaguchi, R. Different antibacterial actions of isoflavones isolated from Erythrina 
poeppigiana against methicillin-resistant Staphylococcus aureus. Lett. Appl. Microbiol. 43, 243–248 (2006).
 11. Mukne, A. P., Viswanathan, V. & Phadatare, A. G. Structure pre-requisites for isoflavones as effective antibacterial agents. 
Pharmacogn. Rev. 5, 13–18 (2011).
 12. Eerdunbayaer, MohamedA. A., Orabi, Hiroe, Aoyama, Kuroda, T. & Hatano, T. Structures of new phenolics isolated from licorice, 
and the effectiveness of licorice phenolics on vancomycin-resistant Enterococci. Molecules 19, 13027–13041 (2014).
 13. Hatano, T. et al. Phenolic constituents of licorice. VIII. Structures of glicophenone and glicoisoflavanone, and effects of licorice 
phenolics on methicillin-resistant Staphylococcus aureus. Chem. Pharm. Bull. 48, 1286–1292 (2000).
 14. Tanaka, H. et al. Antibacterial activity of isoflavonoids isolated from Erythrina variegata against methicillin-resistant Staphylococcus 
aureus. Lett. Appl. Microbiol. 35, 494–498 (2002).
 15. Sato, M. et al. Antibacterial activity of phytochemicals isolated from Erythrina zeyheri against vancomycin-resistant enterococci and 
their combinations with vancomycin. Phytother. Res. 18, 906–910 (2004).
 16. Rao, S. A., Merugu, R. & Rao, M. J. Antibacterial and antifungal studies of prenylated isoflavones and prenylated 3-aryl coumarins 
isolated from Derris scandens BENTH. J. Phcog. 3, 51–54 (2012).
 17. Yin, S., Fan, C.-Q., Wang, Y., Dong, L. & Yue, J.-M. Antibacterial prenylflavone derivatives from Psoralea corylifolia, and their 
structure-activity relationship study. Bioorg. Med. Chem. 12, 4387–4392 (2004).
 18. Zhou, B. & Wan, C.-X. Phenolic constituents from the aerial parts of Glycyrrhiza inflata and their antibacterial activities. J. Asian 
Nat. Prod. Res. 17, 256–261 (2014).
 19. Nanayakkara, N. P. D., Burandt, C. L. & Jacob, M. R. Flavonoids with activity against methicillin-resistant Staphylococcus aureus 
from Dalea scandens var. paucifolia. Planta Med. 68, 519–522 (2002).
 20. Wu, T., Zang, X., He, M., Pan, S. & Xu, X. Structure-activity relationship of flavonoids on their anti-Escherichia coli activity and 
inhibition of DNA gyrase. J. Agric. Food Chem. 61, 8185–8190 (2013).
 21. Villinski, J. R. et al. Pyrano-isoflavans from Glycyrrhiza uralensis with antibacterial activity against Streptococcus mutans and 
Porphyromonas gingivalis. J. Nat. Prod. 77, 521–526 (2014).
 22. Kar, S. & Roy, K. QSAR of phytochemicals for the design of better drugs. Expert Opin. Drug Discov. 7, 877–902 (2012).
 23. Yang, S.-Y. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Dis. Today 15, 
444–450 (2010).
 24. Hendrich, A. B. et al. Differential interaction of Sophora isoflavonoids with lipid bilayers. Eur. J. Pharm. Sci. 16, 201–208 (2002).
 25. Tsuchiya, H. & Iinuma, M. Reduction of membrane fluidity by antibacterial sophoraflavanone G isolated from Sophora exigua. 
Phytomedicine 7, 161–165 (2000).
 26. Wesołowska, O., Gąsiorowska, J., Petrus, J., Czarnik-Matusewicz, B. & Michalak, K. Interaction of prenylated chalcones and 
flavanones from common hop with phosphatidylcholine model membranes. Biochim. Biophys. Acta 1838, 173–184 (2014).
 27. Paterlini, S., Minerva, T. Regression model selection using genetic algorithms. In: Proceedings of the 23rd workshop of the Italian 
Neural Networks Society (ed^(eds). World Scientific and Engineering Academy and Society (WSEAS) (2010).
 28. Xu, L. & Zhang, W.-J. Comparison of different methods for variable selection. Analytica Chimica Acta 446, 475–481 (2001).
 29. Davey, H. M. & Hexley, P. Red but not dead? Membranes of stressed Saccharomyces cerevisiae are permeable to propidium iodide. 
Environ. Microbiol. 13, 163–171 (2011).
 30. Li, X.-Z., Plésiat, P. & Nikaido, H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. 
Rev. 28, 337–418 (2015).
 31. Galdiero, S. et al. Microbe-host interactions: structure and role of Gram-negative bacterial porins. Curr. Protein Peptide Sci. 13, 
843–854 (2012).
 32. Braun, V., Bös, C., Braun, M. & Killmann, H. Outer membrane channels and active transporters for the uptake of antibiotics. J. Infect. 
Dis. 183, S12–S16 (2001).
 33. Nikaido, H. & Rosenberg, E. Y. Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins. J. 
Bacteriol. 153, 241–252 (1983).
 34. Nikaido, H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67, 593–656 (2003).
 35. Black, P. N. & Zhang, Q. Evidence that His'10 of the protein FadL in the outer membrane of Escherichia coli is involved in the binding 
and uptake of long-chain fatty acids: possible role of this residue in carboxylate binding. Biochem. J. 310, 389–394 (1995).
 36. Richter, M. F. et al. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 545, 299–304 (2017).
 37. van den Berg, B. The FadL family: unusual transporters for unusual substrates. Curr. Opin. Struct. Biol. 15, 401–407 (2005).
 38. Hirai, K., Aoyama, H., Irikura, T., Iyobe, S. & Mitsuhashi, S. Differences in susceptibility to quinolones of outer membrane mutants 
of Salmonella Typhimurium and Escherichia coli. Antimicrob. Agents Chemother. 29, 535–538 (1986).
 39. Lambert, P. A. Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria. J. Appl. 
Microbiol. 92, 46S–54S (2002).
 40. Liu, L., Fang, Y. & Wu, J. Flexibility is a mechanical determinant of antimicrobial activity for amphipathic cationic α-helical 
antimicrobial peptides. Biochim. Biophys. Acta 1828, 2479–2486 (2013).
 41. Reißer, S., Strandberg, E., Steinbrecher, T., Ulrich & Anne, S. 3D Hydrophobic moment vectors as a tool to characterize the surface 
polarity of amphiphilic peptides. Biophys. J. 106, 2385–2394 (2014).
 42. Kier, L. B. An index of molecular flexibility from kappa shape attributes. Quant. Struct.-Act. Relat. 8, 221–224 (1989).
 43. Selvaraj, S., Krishnaswamy, S., Devashya, V., Sethuraman, S. & Krishnan, U. M. Influence of membrane lipid composition on 
flavonoid–membrane interactions: Implications on their biological activity. Prog. Lipid Res. 58, 1–13 (2015).
 44. Hendrich, A. B. Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds. 
Acta Pharmacol. Sin. 27, 27–40 (2006).
 45. van de Schans, M. G. M. et al. Involvement of a hydrophobic pocket and helix 11 in determining the modes of action of prenylated 
flavonoids and isoflavonoids in the human estrogen receptor. ChemBioChem 16, 2668–2677 (2015).
 46. van de Schans, M. G. M. et al. Glyceollins and dehydroglyceollins isolated from soybean act as SERMs and ER subtype-selective 
phytoestrogens. J. Steroid Biochem. Mol. Biol. 156, 53–63 (2016).
 47. Bohnert, J. A. & Kern, W. V. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing 
RND efflux pumps. Antimicrob. Agents Chemother. 49, 849–852 (2005).
 48. Aryani, D. C., den Besten, H. M. W., Hazeleger, W. C. & Zwietering, M. H. Quantifying strain variability in modeling growth of 
Listeria monocytogenes. Int. J. Food Microbiol. 208, 19–29 (2015).
 49. Dolezal, R. et al. Towards understanding the mechanism of action of antibacterial N-alkyl-3-hydroxypyridinium salts: Biological 
activities, molecular modeling and QSAR studies. Eur J Med Chem 121, 699–711 (2016).
www.nature.com/scientificreports/
1 4SCIeNTIFIC REPORtS |  (2018) 8:9267  | DOI:10.1038/s41598-018-27545-4
 50. Khazaei, A., Sarmasti, N. & Seyf, J. Y. Quantitative structure–activity relationship of the curcumin-related compounds using various 
regression methods. J. Mol. Struct. 1108, 168–178 (2016).
 51. Westerhuis, J. A. et al. Assessment of PLSDA cross validation. Metabolomics 4, 81–89 (2008).
 52. Gramatica, P. Principles of QSAR models validation: internal and external. QSAR Comb. Sci. 26, 694–701 (2007).
 53. Tropsha, A. Best practices for QSAR model development, validation, and exploitation. Mol. Inform. 29, 476–488 (2010).
 54. Leardi, R. Genetic algorithms in chemistry. J. Chromatogr. A 1158, 226–233 (2007).
 55. Leach, A. Molecular modelling principles and applications. Pearson Education Limited (2001).
 56. Gajo, G. C., de Assis, T. M., Assis, L. C., Ramalho, T. C. & da Cunha, E. F. F. Quantitative structure-activity relationship studies for 
potential Rho-associated protein kinase inhibitors. Journal of Chemistry 2016, 12 (2016).
 57. Assis, T. M. et al. QSAR models guided by molecular dynamics applied to human glucokinase activators. Chem. Biol. Drug Des. 87, 
455–466 (2016).
 58. Roy, K. et al. Some case studies on application of “rm2” metrics for judging quality of quantitative structure–activity relationship 
predictions: Emphasis on scaling of response data. J. Comput. Chem. 34, 1071–1082 (2013).
 59. Roy, K., Kar, S. & Ambure, P. On a simple approach for determining applicability domain of QSAR models. Chemometrics Intellig. 
Lab. Syst. 145, 22–29 (2015).
 60. Singh, N. et al. QSAR classification model for antibacterial compounds and its use in virtual screening. J. Chem. Inf. Model. 52, 
2559–2569 (2012).
Author Contributions
C.A-C., J-P.V., H.M.W.d.B. and H.G. conceptualized the study; C.A-C. and M.G.M.v.d.S. designed and performed 
the experimental work (purification and antibacterial properties of compounds); C.A-C., J.H. and G.S. performed 
the data analysis (molecular modelling and statistical analysis); C.A-C., J-P.V., H.M.W.d.B. and H.G. drafted the 
manuscript. All the authors reviewed the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-27545-4.
Competing Interests: The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
